Deutsche Bank analyst Justin Bowers raised the firm’s price target on Avantor to $25 from $23 and keeps a Hold rating on the shares. The firm’s survey across U.S. academic and clinical research laboratories suggests a softening of the academic and government end market in Q1. It increased earnings estimates and target multiple for Avantor to account for a potential positive earnings revision.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>